Dr. Marc Schwartz, MD
Claim this profileUniversity of Colorado Hospital
Studies Ulcerative Colitis
Studies Cytomegalovirus Colitis
9 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Marc Schwartz, MD is currently running
CAR T Cell Therapy
for Acute Lymphoblastic Leukemia
This trial tests a new treatment using modified immune cells to target and destroy remaining cancer cells in adults with B-ALL who are in remission but still have some cancer left. The goal is to see if this approach is safe and effective. Modified immune cells have shown remarkable success in helping patients with recurring B-ALL achieve remission again.
Recruiting1 award Phase 1
ABX464
for Ulcerative Colitis
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\].
Recruiting1 award Phase 36 criteria
More about Marc Schwartz, MD
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Marc Schwartz, MD has experience with
- ABX464
- Placebo
- UCD19 CAR T
- Gleolan
- Prospective Determination Of The Clinical Utility Of Measurable Residual Disease (MRD) Testing
- PL8177
Breakdown of trials Marc Schwartz, MD has run
Ulcerative Colitis
Cytomegalovirus Colitis
Injection site ulcer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Schwartz, MD specialize in?
Marc Schwartz, MD focuses on Ulcerative Colitis and Cytomegalovirus Colitis. In particular, much of their work with Ulcerative Colitis has involved treating patients, or patients who are undergoing treatment.
Is Marc Schwartz, MD currently recruiting for clinical trials?
Yes, Marc Schwartz, MD is currently recruiting for 5 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Marc Schwartz, MD has studied deeply?
Yes, Marc Schwartz, MD has studied treatments such as ABX464, Placebo, UCD19 CAR T.
What is the best way to schedule an appointment with Marc Schwartz, MD?
Apply for one of the trials that Marc Schwartz, MD is conducting.
What is the office address of Marc Schwartz, MD?
The office of Marc Schwartz, MD is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.